Evidence map›Paper›PMID 26389883›Full record

ArticleInternational journal of molecular sciences2015

In Silico Analysis and Experimental Validation of Active Compounds from Cichorium intybus L. Ameliorating Liver Injury.

Guo-Yu Li, Ya-Xin Zheng, Fu-Zhou Sun, Jian Huang, Meng-Meng Lou, Jing-Kai Gu, Jin-Hui Wang

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. The Synergetic Effect of EgyptianAntioxidants (Basel, Switzerland) · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guo-Yu LiResearch Center for Drug Metabolism, College of Life Science, Jilin University, Changchun 130012, China. gyl197908@163.com.
Ya-Xin ZhengSchool of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China. zhengyaxinxyz@163.com.
Fu-Zhou SunSchool of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China. sunfuzhou1989@126.com.
Jian HuangSchool of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China. profhj@163.com.
Meng-Meng LouSchool of Pharmacy, Shihezi University, Shihezi 832002, China. lmm198508@163.com.
Jing-Kai GuResearch Center for Drug Metabolism, College of Life Science, Jilin University, Changchun 130012, China. gujk@mail.jlu.edu.cn.
Jin-Hui WangSchool of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China. profwjh@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed at investigating the possible mechanisms of hepatic protective activity of Cichorium intybus L. (chicory) in acute liver injury. Pathological observation, reactive oxygen species (ROS) detection and measurements of biochemical indexes on mouse models proved hepatic protective effect of Cichorium intybus L. Identification of active compounds in Cichorium intybus L. was executed through several methods including ultra performance liquid chromatography/time of flight mass spectrometry (UPLC-TOF-MS). Similarity ensemble approach (SEA) docking, molecular modeling, molecular docking, and molecular dynamics (MD) simulation were applied in this study to explore possible mechanisms of the hepato-protective potential of Cichorium intybus L. We then analyzed the chemical composition of Cichorium intybus L., and found their key targets. Furthermore, in vitro cytological examination and western blot were used for validating the efficacy of the selected compounds. In silico analysis and western blot together demonstrated that selected compound 10 in Cichorium intybus L. targeted Akt-1 in hepatocytes. Besides, compound 13 targeted both caspase-1 and Akt-1. These small compounds may ameliorate liver injury by acting on their targets, which are related to apoptosis or autophagy. The conclusions above may shed light on the complex molecular mechanisms of Cichorium intybus L. acting on hepatocytes and ameliorating liver injury.

Indexed as

Molecular Docking SimulationAnimalsApoptosisAutophagyBinding SitesCaspase 1Chemical and Drug Induced Liver InjuryCichorium intybusLiverMicePlant ExtractsProtein BindingProto-Oncogene Proteins c-aktSmall Molecule LibrariesAkt1 protein, mouseCaspase 1Plant ExtractsProto-Oncogene Proteins c-aktSmall Molecule Librariesacute liver injuryAkt-1caspase-1Cichorium intybus L.in silico analysis

Identifiers

PMID26389883
PMCPMC4613303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.